X-50607728-TTCCTCC-TTCCTCCTCC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_020717.5(SHROOM4):c.3411_3413dupGGA(p.Glu1138dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 1,091,571 control chromosomes in the GnomAD database, including 29,069 homozygotes. There are 71,921 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 3319 hom., 6730 hem., cov: 14)
Exomes 𝑓: 0.28 ( 25750 hom. 65191 hem. )
Consequence
SHROOM4
NM_020717.5 disruptive_inframe_insertion
NM_020717.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.350
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-50607728-T-TTCC is Benign according to our data. Variant chrX-50607728-T-TTCC is described in ClinVar as [Benign]. Clinvar id is 95971.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHROOM4 | NM_020717.5 | c.3411_3413dupGGA | p.Glu1138dup | disruptive_inframe_insertion | 6/9 | ENST00000376020.9 | NP_065768.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHROOM4 | ENST00000376020.9 | c.3411_3413dupGGA | p.Glu1138dup | disruptive_inframe_insertion | 6/9 | 2 | NM_020717.5 | ENSP00000365188.2 | ||
SHROOM4 | ENST00000289292.11 | c.3411_3413dupGGA | p.Glu1138dup | disruptive_inframe_insertion | 6/10 | 1 | ENSP00000289292.7 | |||
SHROOM4 | ENST00000460112.3 | c.3063_3065dupGGA | p.Glu1022dup | disruptive_inframe_insertion | 5/8 | 5 | ENSP00000421450.1 |
Frequencies
GnomAD3 genomes AF: 0.273 AC: 28804AN: 105509Hom.: 3329 Cov.: 14 AF XY: 0.235 AC XY: 6729AN XY: 28603
GnomAD3 genomes
AF:
AC:
28804
AN:
105509
Hom.:
Cov.:
14
AF XY:
AC XY:
6729
AN XY:
28603
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.212 AC: 26912AN: 127114Hom.: 1812 AF XY: 0.103 AC XY: 3362AN XY: 32658
GnomAD3 exomes
AF:
AC:
26912
AN:
127114
Hom.:
AF XY:
AC XY:
3362
AN XY:
32658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.283 AC: 278624AN: 986025Hom.: 25750 Cov.: 30 AF XY: 0.229 AC XY: 65191AN XY: 284763
GnomAD4 exome
AF:
AC:
278624
AN:
986025
Hom.:
Cov.:
30
AF XY:
AC XY:
65191
AN XY:
284763
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.273 AC: 28779AN: 105546Hom.: 3319 Cov.: 14 AF XY: 0.235 AC XY: 6730AN XY: 28652
GnomAD4 genome
AF:
AC:
28779
AN:
105546
Hom.:
Cov.:
14
AF XY:
AC XY:
6730
AN XY:
28652
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 29, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 19, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 11, 2013 | - - |
X-linked intellectual disability, Stocco dos Santos type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at